MIRA
INFORM REPORT
|
Report Date : |
28.12.2007 |
IDENTIFICATION
DETAILS
|
Name : |
DELTAPHARM LTD |
|
|
|
|
Registered Office : |
Rm D, 6FL Mai On Industrial Bldg 17-21 Kung Yip St, Kwai
Hing New Territories |
|
|
|
|
Country : |
Hong Kong |
|
|
|
|
Date of Incorporation : |
March 13, 1998 |
|
|
|
|
Com. Reg. No.: |
0639321 |
|
|
|
|
Legal Form : |
Private |
|
|
|
|
Line of Business : |
Importing and local purchasing of pharmaceutical products. Distribution of products to local market. |
RATING &
COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Small Company |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
name & address
DELTAPHARM LTD
RM D, 6FL MAI ON INDUSTRIAL BLDG 17-21 KUNG YIP ST
KWAI HING NEW TERRITORIES, HONG KONG.
TEL : 852-31136103
FAX : 852-24335356
EXECUTIVE SUMMARY
INCORPORATION DATE :
MARCH 13, 1998
REGISTRATION NO. :
0639321
LEGAL FORM :
PRIVATE
CHIEF EXECUTIVE :
MR. CHUNG-LING LAM (CHAIRMAN)
STAFF STRENGTH :
10
CAPITAL :
US$ 1,284
BUSINESS LINE :
TRADER
TURNOVER :
N/A (AS OF DEC. 31, 2006)
EQUITIES :
N/A (AS OF DEC. 31, 2006)
PAYMENT :
FAIR
RECOMM. CREDIT RANGE : SMALL
AMOUNT
MARKET CONDITION :
AVERAGE
FINANCIAL CONDITION :
N/A
OPERATIONAL TREND : STEADY
GENERAL REPUTATION :
AVERAGE
EXCHANGE RATE :
HKD 7.79975 = US$1
Adopted abbreviations:
ANS - amount not stated
NS - not stated
SC - subject company (the company inquired by you)
NA - not available
M – million
HKD –Hong Kong Dollars
Note: SC’s registered address is Flat D 22Fl
Bold Win Industrial Bldg 16-18 Wah Sing St Kwai Hing New Territories, Hong
Kong. Its operational address is the heading one.
*Company Registration*
===================
(1)
License number : 0639321
Date issued : 13 March,
1998
Issuing authority : Companies
Registry
Type of license : Corporate
(2)
License number : 21598793
Issuing authority : Business
Registration Office - Inland Revenue Dept
Type of license : Business
*Licenses & Permits*
=================
(1)
License number : HK-55681
Issuing authority : Department
of Health
Type of license : Permitted
to distribute Lincomycin drugs.
(2)
License number : KK-44257
Type of license : Permitted
to distribute Famotidine (An active pharmaceutical ingredients)
*Registrar*
========
T & P CONSULTANTS CO LTD
*Capital Details*
=============
Authorized capital : HKD 10,000.00 divided into 10,000 ordinary shares
of HKD 1.00/-each, fully paid
*Reputation*
==========
Reference checking for the purpose of establishing the firm's reputation
within the respective industry failed to reveal any negative information.
*Approved Signatures*
===================
Mr. Chung-ling Lam can sign on behalf of the company with seal affixed.
SC is not known to host website of its own at present.
E-mail: deltapharm@i-cable.com
For the past two years there is no record of litigation.
*Major Shareholders*
================
Total number of shareholders
: 3
Total number of ordinary shares : 10,000
Shareholders' Name No. of
Ordinary Shares Amount of Shares
(HKD) % of Shares
-------------------------
----------------------------
--------------------------------
----------------
Chung-ling Lam
5,000
5,000.00 50.00
Man-yuen Chan 4,500 4,500.00 45.00
Sau-kam Leung
500
500.00 5.00
*Director's Details*
===============
Man-yuen Chan
HKID number : E831902(6)
Address : Rm 2601 Lung
Chu House Lung Poon Court Diamond Hill, Kowloon Hong Kong
Shareholder's Details
----------------------------
Sau-kam Leung
Address : Rm 2601 Lung
Chu House Lung Poon Court Diamond Hill, Kowloon Hong Kong
*Key Personnel*
=============
Chung-ling Lam
HKID number : E383077 (6)
Mobile number : 91918163
Address : Flat H 10Fl
Hoi Kwun Mansion Riviera Gardens Tsuen Wan New Territories Hong Kong
Responsibility : Handles the
overall management of the company.
*Main Products & Services*
=====================
Specializes in the following areas of work:
1. Importing and local purchasing of pharmaceutical products.
2. Distribution of products to local market.
Products: Active pharma ingredients
Lincomycin
Pharmaceutical
products
*Brand*
======
Famonox Tab
*Payment Terms*
==============
Sales
-------
Local : Cash or Credit
Purchases
--------------
Local : Cash or Credit
Import : Letter of Credit (L/C)
*Local Distribution Network*
=======================
100% of the annual turnover is attributed to local sales.
*Export Markets*
==============
There is no record of export since the prime focus of the firm's
activity is concentrated on local sales only.
*Export Markets*
==============
There is no record of export since the prime focus of the firm's
activity is concentrated on local sales only.
SC is not known to have any subsidiary at
present.
PAYMENT
RATING : 4 OBTAINED SCORES :
48
|
Implication |
Implications |
|
|
1 |
Scores 85–100 |
Excellent |
|
2 |
Scores 75 – 84 |
Above Average |
|
3 |
Scores 50 – 74 |
Average |
|
4 |
Scores 35 – 49 |
Fair |
|
5 |
Scores 15 – 34 |
Below Average |
|
6 |
Scores 01 – 14 |
Poor |
|
NR |
No Data |
No Data |
The rating indicates the payment
pattern of SC based upon our Payment Database, comments from suppliers of SC,
information from banks (if available), as well as industrial sources.
Dealings on open terms may be possible for SMALL amounts depending
on individual judgement experience.
As a private limited company there is no legal requirement according to
local corporate law for public disclosure of detailed financials.
SC is considered small-sized in its line with a development history of 9
years. Credit dealings with SC should be confined into small amount at present.
Attached:
trade references
SIC PRODUCT CLASSIFICATION & ACTIVITY
Activity Code Product/Service Description
Importing 2834 Pharmaceutical
preparations
Trading 2834 Pharmaceutical
preparations
HARMONIZED PRODUCT CLASSIFICATION & ACTIVITY
Activity Code Product/Service Description
Importing 3000 Pharmaceutical
products
Trading 3000 Pharmaceutical
products
DETAILED PRODUCT
CLASSIFICATION & ACTIVITY
Activity Product/Service Description
Trader Active pharma
ingredients
INTERNATIONAL
TRADE: ACTIVITY & MARKETS
Importing from Asia
Importing from Europe
Importing from North America
Importing from USA
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)